Drug Database
Back to search

Netherlands· NL-d604983f4c1d

Suprefact Depot 3 maanden, implantatiestift 9,45 mg

A buserelin product containing buserelineacetaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC L02AE01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSuprefact Depot 3 maanden, implantati…ATCL02AE01REGISTER NO.NL-d604983f4c1dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about buserelineacetaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Buserelin is registered in 8 of 19 countries.

Countries holding a registration under ATC L02AE01 (buserelin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search buserelin products by name

Buserelin · ATC L02AE01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUSERELINEACETAAT
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
L02AE01
ATC class
Buserelin
Defined daily dose
0.11 mg, Implantat
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    126802//21170

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Buserelin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buserelin products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Suprecur, Suprefact
  • Bulgaria · Супрефакт Депо 3 Месеца
  • Germany · Profact Depot, Profact Pro Injectione
  • Spain · Suprefact, Suprefact Depot
  • United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
  • Greece · Suprefact Depot 3 Μήνεσ
  • Hungary · Suprefact
  • Italy · Suprefact, Suprefact Depot
  • Sweden · Suprecur, Suprefact

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3811e8a5-ffb2-466f-9de9-d8c2b09c5789
GET /v1/drugs/3811e8a5-ffb2-466f-9de9-d8c2b09c5789?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Implantaat",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21170_smpc.pdf",
  "strength": null,
  "atc_label": "Buserelin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126802",
  "excipients": [
    "MELKZUUR(D,L)-GLYCOLZUUR COPOLYMEER"
  ],
  "substances": [
    "BUSERELINEACETAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126802.pdf",
  "authorised_at": "2020/07/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126802//21170",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about buserelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console